111 related articles for article (PubMed ID: 163727)
1. [The vaso-active intestinal polypeptide in Verner-Morrison syndrome].
Seif FJ; Sadowski P; Heni F; Fischer R; Bloom SR; Polak JM
Dtsch Med Wochenschr; 1975 Feb; 100(9):399-405. PubMed ID: 163727
[TBL] [Abstract][Full Text] [Related]
2. [VIP and GIP-producing pancreatic tumour: relationship to the Verner-Morrison syndrome].
Kunert H; Kuhn FM; Schwemmle K; Ottenjann R
Dtsch Med Wochenschr; 1976 Jun; 101(24):920-3. PubMed ID: 179772
[TBL] [Abstract][Full Text] [Related]
3. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
Fahrenkrug J; Schaffalitzky de Muckadell OB
Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
Judge DM; Demers LM; Nahrwold DL; Dickman PS; Petrokubi RJ; Trapukdi S
Arch Pathol Lab Med; 1977 May; 101(5):262-5. PubMed ID: 192171
[TBL] [Abstract][Full Text] [Related]
5. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
[TBL] [Abstract][Full Text] [Related]
6. Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses.
Gagel RF; Costanza ME; DeLellis RA; Norton RA; Bloom SR; Miller HH; Ucci A; Nathanson L
Arch Intern Med; 1976 Dec; 136(12):1429-35. PubMed ID: 187136
[TBL] [Abstract][Full Text] [Related]
7. Streptozotocin treatment of a juvenile onset type diabetic patient with Verner-Morrison syndrome and multi hormonal probable malignant islet cell carcinoma with liver metastases.
Granuci P; Mahler RJ
Horm Metab Res; 1982 Jun; 14(6):327-8. PubMed ID: 6288539
[No Abstract] [Full Text] [Related]
8. Streptozotocin treatment of a pancreatic tumour producing VIP and gastrin associated with Verner-Morrison syndrome.
Oberg K; Boström H; Fahrenkrug J; Dymling JF; Shaffalitsky de Muckadell OB; Lundqvist G
Acta Med Scand; 1979; 206(3):223-7. PubMed ID: 227234
[TBL] [Abstract][Full Text] [Related]
9. Proceedings: Vasoactive intestinal peptide and the Verner-Morrison syndrome.
Bloom SR
Gut; 1975 May; 16(5):399. PubMed ID: 166903
[No Abstract] [Full Text] [Related]
10. [Verner-Morrison syndrome].
Seitz HD; Springorum HW
Chirurg; 1975 May; 46(5):225-8. PubMed ID: 168042
[TBL] [Abstract][Full Text] [Related]
11. A patient with Verner-Morrison's syndrome--a vasoactive intestinal peptide (VIP)-mediated watery diarrhoea syndrome?
Meuwese-Arends MT; Yap SH; Van Tongeren JH
Neth J Med; 1980; 23(2):107-10. PubMed ID: 6246463
[No Abstract] [Full Text] [Related]
12. Report of a pancreatic polypeptide-producing islet-cell tumour of the pancreas causing the watery diarrhoea, hypokalaemia, achlorhydria syndrome in a 55 year old Zimbabwean African male.
Hayes MM
Cent Afr J Med; 1980 Sep; 26(9):195-7. PubMed ID: 6258796
[No Abstract] [Full Text] [Related]
13. VIPomas and the watery diarrhoea syndrome.
Modlin IM; Bloom SR
S Afr Med J; 1978 Jul; 54(2):53-6. PubMed ID: 705537
[TBL] [Abstract][Full Text] [Related]
14. VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.
Bloom SR; Polak JM
Clin Endocrinol (Oxf); 1976; 5 Suppl():223S-228S. PubMed ID: 212228
[TBL] [Abstract][Full Text] [Related]
15. Hypersecretion of calcitonin in patients with the Verner-Morrison syndrome.
Oberg K; Lööf L; Boström H; Grimelius L; Fahrenkrug J; Lundqvist G
Scand J Gastroenterol; 1981; 16(1):135-44. PubMed ID: 6262904
[TBL] [Abstract][Full Text] [Related]
16. Resolution of recurrent Verner-Morrison syndrome by resection of metastatic vipoma.
Nagorney DM; Bloom SR; Polak JM; Blumgart LH
Surgery; 1983 Feb; 93(2):348-53. PubMed ID: 6297109
[TBL] [Abstract][Full Text] [Related]
17. [Islet cell adenomatosis associated with therapy watery diarrhea and hypokalemia. (Verner-Morrison Syndrome)].
Schoenemann J; Zastrow R; Herzog KH; Putzke HP
Dtsch Z Verdau Stoffwechselkr; 1972; 32(3):229-38. PubMed ID: 4345474
[No Abstract] [Full Text] [Related]
18. [G.I.P. (gastric inhibitory polypeptide) and the WDHA (Verner-Morrison) syndrome].
Schmidt-Wilcke HA
Internist (Berl); 1973 Apr; 14(4):179-80. PubMed ID: 4351862
[No Abstract] [Full Text] [Related]
19. Effects fo streptozotocin in the WDHA syndrome not amenable to radical surgery.
Biliotti G; Masi C; Macchini M; Bani Sacchi T; Bartolini G; Stefani P; Tonelli F
J Endocrinol Invest; 1980; 3(3):297-300. PubMed ID: 6253557
[TBL] [Abstract][Full Text] [Related]
20. [Vasoactive intestinal polypeptide in digestive processes in the Verner Morrison syndrome].
Leonardi R; Toffoli C; Rigamonti L; Rigamonti D; Gambassi G; Greco A; Ghirlanda G
Minerva Med; 1981 Jun; 72(26):1707-11. PubMed ID: 6265832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
